共 50 条
- [2] An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2014, 44 (03) : 253 - 263
- [5] Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 48 (01) : 1 - 8
- [6] Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) [J]. Aging Clinical and Experimental Research, 2018, 30 : 111 - 117
- [7] RECOMMENDATIONS FOR THE REPORTING OF HARMS IN MANUSCRIPTS ON STUDIES ASSESSING OSTEOARTHRITIS DRUGS: A CONSENSUS STATEMENT FROM THE EUROPEAN SOCIETY FOR CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES (ESCEO) [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S569 - S570
- [8] Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) [J]. Drugs & Aging, 2019, 36 : 145 - 159
- [9] Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 30 (02) : 111 - 117
- [10] Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) [J]. DRUGS & AGING, 2019, 36 (Suppl 1) : 145 - 159